Medical
Pharmaceutical
Europe

Horizon Pharma

$26.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.07 (-3.83%) Today
-$0.33 (-1.23%) After Hours

Why Robinhood?

You can buy or sell Horizon Pharma and other stocks, options, ETFs, and crypto commission-free!

About

Horizon Pharma plc Ordinary Shares (Ireland), also called Horizon Pharma, is a biopharmaceutical company which is engaged in the research, development and market of pharmaceutical products. The medicines intend to treat arthritis, inflammation and orphan diseases. Read More It distributes its products under the brands such as Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid, Ravicti, Rayos and Vimovo. The company was founded in 2008 and is headquartered in Dublin, Ireland.

Employees
1,000
Headquarters
Dublin, Dublin
Founded
2008
Market Cap
4.71B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.77M
High Today
$27.80
Low Today
$26.55
Open Price
$27.72
Volume
795.14K
52 Week High
$29.44
52 Week Low
$12.55

Collections

Medical
Pharmaceutical
Europe
Health
Research And Development
Europe (Non-UK)
Healthcare
Technology

News

Yahoo FinanceMar 21

Edited Transcript of HZNP earnings conference call or presentation 27-Feb-19 1:00pm GMT

Q4 2018 Horizon Pharma PLC Earnings Call Dublin Mar 21, 2019 (Thomson StreetEvents) -- Edited Transcript of Horizon Pharma PLC earnings conference call or presentation Wednesday, February 27, 2019 at 1:00:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Paul W. Hoelscher Horizon Pharma plc - Executive VP & CFO * Robert F. Carey ...

16
Associated PressMar 18

Horizon Pharma plc Wins PR News CSR Award for Partnership with Perspectives Math and Science Academy

This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation. DUBLIN--(BUSINESS WIRE)--Mar 18, 2019--Horizon Pharma plc (Nasdaq: HZNP) announced today that it has won a PR News CSR Award in the Corporation category for its impactful partnership with Chicago-based charter school, Perspectiv...

77
Yahoo FinanceMar 11

Horizon Pharma plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

DUBLIN--(BUSINESS WIRE)-- -- Total offering size of $345 million – -- Incremental $200 million borrowing capacity secured under new revolving credit facility -- Horizon Pharma plc (HZNP) today announced the closing of its underwritten public offering of 14,081,632 of its ordinary shares at a price to the public of $24.50 per share. This includes the exercise in full by the underwriters of their option to purchase up to 1,836,734 additional ordinary shares. The estimated net proceeds to the Company from t...

419

Earnings

$0.03
$0.24
$0.46
$0.67
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.